Additive Effect of Adherence to Multiple Healthy Behaviors on Subclinical...
What is the relationship between adherence to multiple healthy lifestyle behaviors and subclinical atherosclerosis?
View ArticleHypertriglyceridemia Management According to the 2018 AHA/ACC Guideline
The 2018 AHA/ACC Guideline on the Management of Blood Cholesterol was a welcome update from the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular...
View ArticleLess Than Six Hours of Sleep a Night May Increase Atherosclerosis
People who sleep less than six hours a night may be at increased risk of atherosclerosis compared with those who sleep between seven and eight hours, according to a study published Jan. 14 in the...
View ArticleNumber Check | Wellness and Heart Disease
Wellness and Heart Disease... By the Numbers.
View ArticleEditor's Corner | The Behavioral Side of Personal Health
Most of the information we exchange with our medical colleagues is focused on sharing the most recent clinical trials and interpreting outcomes from clinical trials that can benefit our patients, along...
View ArticleEfficacy and Safety of Statin Therapy in Older People: Meta-Analysis
The following are key points to remember from this meta-analysis of data from 28 trials on the efficacy and safety of statin therapy in older people.
View ArticleDiabetes in Heart Failure With Preserved Ejection Fraction
The following are key points to remember from this review on heart failure with preserved ejection fraction (HFpEF) and diabetes.
View ArticleEagle's Eye View: Your Weekly CV Update From ACC.org (Week of February 4)
This week's View offers key points to remember from a review on heart failure with preserved ejection fraction and diabetes and addresses the comparative durabilities of transcatheter aortic valve...
View ArticleTriglycerides, Remnant Cholesterol and Atherosclerotic Cardiovascular Disease
Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death worldwide. Elevated low-denisty lipoprotein-cholesterol (LDL-C) is an established risk factor for ASCVD and primary...
View ArticleESC Position Paper on Depression and CHD
The following are key perspectives from the recent European Society of Cardiology (ESC) Position Paper on depression and coronary heart disease (CHD).
View ArticlePrevention: The Best Offensive Line
The best offense — our most powerful tool – to combat heart disease is prevention. Fittingly, this theme, along with innovation, is embedded in the ACC.19 education and science programming.
View ArticleNonalcoholic Fatty Liver Disease and the Heart
The following are key points to remember from this review on nonalcoholic fatty liver disease and the heart.
View ArticleNut Intake, CVD Risk, and Mortality Among Diabetes Patients
Does nut consumption lower the risk for cardiovascular disease (CVD) among adults with type 2 diabetes mellitus (T2DM)?
View ArticleValue of Measuring Lp(a) During Cascade Testing for FH
Is lipoprotein (a) [Lp(a)] effective in detecting and risk stratifying individuals participating in a familial hypercholesterolemia (FH) cascade screening program?
View ArticleImportant Trial Results for Interventional Cardiology From AHA 2018
Although the American Heart Association Scientific Sessions 2018 (AHA 2018) was not an interventional-focused meeting, AHA 2018 had a strong selection of late-breaking science that impacted...
View ArticleLeisure-Time Physical Activity Across Adult Life and Mortality
Does an association exist between leisure-time physical activity (LTPA) life course patterns and mortality?
View ArticleACC.19 Consumer Research Highlights
Several studies exploring smartphone technology, diet and exercise, drug use and cardiac infection, hyperlipidemia in pregnancy, and cardiovascular disease in cancer patients will be presented during...
View Article